Back to mobile site

Citizens Reiterates Market Outperform Rating on Solid Biosciences (SLDB)

March 16, 2026 5:03 AM EDT Send to a Friend
Citizens analyst Silvan Turkcan reiterated a Market Outperform rating and $15.00 price target on Solid Biosciences (NASDAQ: SLDB).The analyst commented ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login